184473-60-7

Basic information

• Product Name: 2-(4-bromo-2,5-dimethoxyphenyl)ethanol
• Synonyms: 2-(4-bromo-2,5-dimethoxyphenyl)ethanol
• CAS NO: 184473-60-7
• Molecular Weight: 261.115
• Mol File: 184473-60-7.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 2-(4-bromo-2,5-dimethoxyphenyl)ethanol(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(4-bromo-2,5-dimethoxyphenyl)ethanol(184473-60-7)
• EPA Substance Registry System: 2-(4-bromo-2,5-dimethoxyphenyl)ethanol(184473-60-7)

Safety Data

• Hazardous Substances Data: 184473-60-7(Hazardous Substances Data)

Upstream product

• 75-21-8 oxirane 
• 2674-34-2 1,4-dibromo-2,5-dimethoxybenzene 
• 7417-19-8 2-(2,5-dimethoxyphenyl)ethanol 
• 128-08-5 N-Bromosuccinimide 
• 681171-54-0 [2-(2,5-dimethoxy-phenyl)-ethoxy]-dimethyl-silane 
• 1758-25-4 (2,5-dimethoxyphenyl)acetic acid 
• 184473-59-4 4-bromo-2,5-dimethoxyphenylacetic acid 

Downstream Products

• 1746-29-8 bromo-4-(2-bromo-ethyl)-2,5-dimethoxy-benzene 
• 712293-13-5 1-bromo-2,5-dimethoxy-4-(2-methoxymethoxy-ethyl)-benzene 
• 40492-53-3 2,3-dihydro-6-bromo-5-hydroxybenzofuran 
• 894803-86-2 N-(4-amino-5-cyano-6-ethoxy-pyridin-2-yl)-2-(4-methanesulfonyl-2,5-dimethoxy-phenyl)-acetamide 
• 894803-69-1 (4-methanesulfonyl-2,5-dimethoxyphenyl)acetic acid 
• 904311-61-1 2-(4-methanesulfonyl-2,5-dimethoxyphenyl)ethanol 
• 894803-66-8 (4-methanesulfonyl-2,5-dimethoxyphenyl)acetyl chloride 
• 894803-67-9 2-(2,5-dimethoxy-4-methylsulfanylphenyl)ethanol 
• 681171-56-2 [2-(4-bromo-2,5-dimethoxyphenyl)ethoxy]-tert-butyldimethylsilane 
• 184473-61-8 2,5-dihydroxy-4-bromophenethylbromide 

Relevant articles and documents

Inhibitors of c-Jun N-terminal kinases

The present invention relates to compounds that are inhibitors of c-jun N-terminal kinase 1, 2, or 3 (JNK1, JNK2, or JNK3), compositions containing the compounds and the use of the compounds in the prevention or treatment of disorders regulated by the activation of JNK1, JNK2 and JNK3.

2-amino-6-(2,4,5-substituted-phenyl)-pyridines

The invention provides compounds of formula VI and the pharmaceutically acceptable salts thereof, wherein R1, R2, R3, and R4 are as defined, to pharmaceutical compositions containing such compounds and to the use of such compounds in the treatment and prevention of central nervous system and other disorders. The invention also provides methods for inhibiting neurological damage caused by impairment of glucose and/or oxygen to the brain in a mammal, which method comprises administering to the mammal a NOS inhibitor. In one embodiment, the NOS inhibitor is administered to the mammal prior to surgery, for example prior to cardiac surgery, angioplasty, or angiography.